Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function

被引：0

作者：

S. L. Wong

S. Menacherry

D. Mulford

P. J. Schmitz

C. Locke

G. R. Granneman

机构：

[1] Department of Pharmacokinetics and Biopharmaceutics,

[2] D4PK,undefined

[3] AP 13A,undefined

[4] Abbott Laboratories,undefined

[5] 100 Abbott Park Road,undefined

[6] Abbott Park,undefined

[7] IL 60064-3500,undefined

[8] USA Tel. +1-847-938-0312; Fax +1-847-938-5193; e-mail shekman.wong@abbott.com,undefined

[9] Drug Analysis Department,undefined

[10] Abbott Laboratories,undefined

[11] USA,undefined

[12] Biotransformation Department,undefined

[13] Abbott Laboratories,undefined

[14] USA,undefined

[15] Psychopharmacology Venture,undefined

[16] Abbott Laboratories,undefined

[17] USA,undefined

[18] Biostatistics Department,undefined

[19] Abbott Laboratories,undefined

[20] USA,undefined

来源：

European Journal of Clinical Pharmacology | 1997年 / 52卷

关键词：

Key words Sertindole; Renal impairment; pharmacoki netics; hemodialysis; schizophrenia; antipsychotics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objective: To study the effect of renal impairment on the pharmacokinetics of sertindole.

引用

页码：223 / 227

页数：4

共 50 条

[1] Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function
Wong, SL
Menacherry, S
Mulford, D
Schmitz, PJ
Locke, C
Granneman, GR
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (03) : 223 - 227
[2] PHARMACOKINETICS OF CEFODIZIME IN VOLUNTEERS WITH NORMAL OR IMPAIRED RENAL-FUNCTION
CONTE, JE
JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (11): : 1066 - 1070
[3] PHARMACOKINETICS OF CEFPIRAMIDE IN VOLUNTEERS WITH NORMAL OR IMPAIRED RENAL-FUNCTION
CONTE, JE
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (10) : 1585 - 1588
[4] PHARMACOKINETICS OF CINOXACIN IN NORMAL VOLUNTEERS AND PATIENTS WITH IMPAIRED RENAL-FUNCTION
OHKAWA, M
SUGATA, T
SAWAKI, M
OKASHO, A
KURODA, K
YAMADA, H
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 (06) : 447 - 451
[5] Pharmacokinetics of azithromycin in normal and impaired renal function
Hoffler, D
Koeppe, P
Paeske, B
INFECTION, 1995, 23 (06) : 356 - 361
[6] Biapenem pharmacokinetics in healthy volunteers and in patients with impaired renal function
Koeppe, P
Höffler, D
Fitzen, B
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1997, 47 (11): : 1250 - 1256
[7] The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment vs volunteers with normal renal function
Fragen, RJ
De Wolf, AM
Avram, MJ
Fitzgerald, PC
ANESTHESIOLOGY, 1998, 89 (3A) : U382 - U382
[8] Raloxifene pharmacokinetics in males with normal and impaired renal function
Czock, D
Keller, F
Heringa, M
Rasche, FM
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (04) : 479 - 482
[9] ON THE PHARMACOKINETICS OF LATAMOXEF IN NORMAL AND IMPAIRED RENAL-FUNCTION
HOFFLER, D
KOEPPE, P
MOECKE, D
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1984, 34-1 (03): : 317 - 320
[10] PHARMACOKINETICS OF PEFLOXACIN IN NORMAL AND IMPAIRED RENAL-FUNCTION
HOFFLER, D
SCHAFER, I
KOEPPE, P
SORGEL, F
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (05): : 739 - 743

← 1 2 3 4 5 →